Literature DB >> 32152541

A bifunctional O-antigen polymerase structure reveals a new glycosyltransferase family.

Bradley R Clarke1, Olga G Ovchinnikova1, Ryan P Sweeney2, Evelyn R Kamski-Hennekam1, Russel Gitalis1, Evan Mallette1, Steven D Kelly1, Todd L Lowary2, Matthew S Kimber3, Chris Whitfield4.   

Abstract

Lipopolysaccharide O-antigen is an attractive candidate for immunotherapeutic strategies targeting antibiotic-resistant Klebsiella pneumoniae. Several K. pneumoniae O-serotypes are based on a shared O2a-antigen backbone repeating unit: (→ 3)-α-Galp-(1 → 3)-β-Galf-(1 →). O2a antigen is synthesized on undecaprenol diphosphate in a pathway involving the O2a polymerase, WbbM, before its export by an ATP-binding cassette transporter. This dual domain polymerase possesses a C-terminal galactopyranosyltransferase resembling known GT8 family enzymes, and an N-terminal DUF4422 domain identified here as a galactofuranosyltransferase defining a previously unrecognized family (GT111). Functional assignment of DUF4422 explains how galactofuranose is incorporated into various polysaccharides of importance in vaccine production and the food industry. In the 2.1-Å resolution structure, three WbbM protomers associate to form a flattened triangular prism connected to a central stalk that orients the active sites toward the membrane. The biochemical, structural and topological properties of WbbM offer broader insight into the mechanisms of assembly of bacterial cell-surface glycans.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32152541     DOI: 10.1038/s41589-020-0494-0

Source DB:  PubMed          Journal:  Nat Chem Biol        ISSN: 1552-4450            Impact factor:   15.040


  45 in total

1.  Functional analysis of the galactosyltransferases required for biosynthesis of D-galactan I, a component of the lipopolysaccharide O1 antigen of Klebsiella pneumoniae.

Authors:  S Guan; A J Clarke; C Whitfield
Journal:  J Bacteriol       Date:  2001-06       Impact factor: 3.490

2.  A membrane-located glycosyltransferase complex required for biosynthesis of the D-galactan I lipopolysaccharide O antigen in Klebsiella pneumoniae.

Authors:  Veronica Kos; Chris Whitfield
Journal:  J Biol Chem       Date:  2010-04-21       Impact factor: 5.157

Review 3.  Biosynthesis and export of bacterial lipopolysaccharides.

Authors:  Chris Whitfield; M Stephen Trent
Journal:  Annu Rev Biochem       Date:  2014-02-21       Impact factor: 23.643

4.  Role of Rfe and RfbF in the initiation of biosynthesis of D-galactan I, the lipopolysaccharide O antigen from Klebsiella pneumoniae serotype O1.

Authors:  B R Clarke; D Bronner; W J Keenleyside; W B Severn; J C Richards; C Whitfield
Journal:  J Bacteriol       Date:  1995-10       Impact factor: 3.490

5.  Cross-specificity of protective human antibodies against Klebsiella pneumoniae LPS O-antigen.

Authors:  Tim Rollenske; Valeria Szijarto; Jolanta Lukasiewicz; Luis M Guachalla; Katarina Stojkovic; Katharina Hartl; Lukas Stulik; Simone Kocher; Felix Lasitschka; Mohammed Al-Saeedi; Jutta Schröder-Braunstein; Moritz von Frankenberg; Gereon Gaebelein; Peter Hoffmann; Sabrina Klein; Klaus Heeg; Eszter Nagy; Gabor Nagy; Hedda Wardemann
Journal:  Nat Immunol       Date:  2018-05-14       Impact factor: 25.606

Review 6.  Lipopolysaccharide transport and assembly at the outer membrane: the PEZ model.

Authors:  Suguru Okuda; David J Sherman; Thomas J Silhavy; Natividad Ruiz; Daniel Kahne
Journal:  Nat Rev Microbiol       Date:  2016-03-30       Impact factor: 60.633

7.  Identification of an ATP-binding cassette transport system required for translocation of lipopolysaccharide O-antigen side-chains across the cytoplasmic membrane of Klebsiella pneumoniae serotype O1.

Authors:  D Bronner; B R Clarke; C Whitfield
Journal:  Mol Microbiol       Date:  1994-11       Impact factor: 3.501

8.  Immune stealth-driven O2 serotype prevalence and potential for therapeutic antibodies against multidrug resistant Klebsiella pneumoniae.

Authors:  Meghan E Pennini; Anna De Marco; Mark Pelletier; Jessica Bonnell; Romana Cvitkovic; Martina Beltramello; Elisabetta Cameroni; Siro Bianchi; Fabrizia Zatta; Wei Zhao; Xiaodong Xiao; Maria M Camara; Antonio DiGiandomenico; Elena Semenova; Antonio Lanzavecchia; Paul Warrener; JoAnn Suzich; Qun Wang; Davide Corti; C Kendall Stover
Journal:  Nat Commun       Date:  2017-12-08       Impact factor: 14.919

9.  The diversity of Klebsiella pneumoniae surface polysaccharides.

Authors:  Rainer Follador; Eva Heinz; Kelly L Wyres; Matthew J Ellington; Michael Kowarik; Kathryn E Holt; Nicholas R Thomson
Journal:  Microb Genom       Date:  2016-08-25

10.  Development of a broad spectrum glycoconjugate vaccine to prevent wound and disseminated infections with Klebsiella pneumoniae and Pseudomonas aeruginosa.

Authors:  Nicolas Hegerle; Myeongjin Choi; James Sinclair; Mohammed N Amin; Morgane Ollivault-Shiflett; Brittany Curtis; Rachel S Laufer; Surekha Shridhar; Jerod Brammer; Franklin R Toapanta; Ian Alan Holder; Marcela F Pasetti; Andrew Lees; Sharon M Tennant; Alan S Cross; Raphael Simon
Journal:  PLoS One       Date:  2018-09-06       Impact factor: 3.240

View more
  4 in total

1.  Chlorovirus PBCV-1 Multidomain Protein A111/114R Has Three Glycosyltransferase Functions Involved in the Synthesis of Atypical N-Glycans.

Authors:  Eric Noel; Anna Notaro; Immacolata Speciale; Garry A Duncan; Cristina De Castro; James L Van Etten
Journal:  Viruses       Date:  2021-01-10       Impact factor: 5.048

Review 2.  Lipopolysaccharide O-antigens-bacterial glycans made to measure.

Authors:  Chris Whitfield; Danielle M Williams; Steven D Kelly
Journal:  J Biol Chem       Date:  2020-05-18       Impact factor: 5.157

3.  Chlorovirus PBCV-1 protein A064R has three of the transferase activities necessary to synthesize its capsid protein N-linked glycans.

Authors:  Immacolata Speciale; Maria Elena Laugieri; Eric Noel; Sicheng Lin; Todd L Lowary; Antonio Molinaro; Garry A Duncan; Irina V Agarkova; Domenico Garozzo; Michela G Tonetti; James L Van Etten; Cristina De Castro
Journal:  Proc Natl Acad Sci U S A       Date:  2020-11-02       Impact factor: 11.205

4.  Successful treatment of infective endocarditis due to pandrug-resistant Klebsiella pneumoniae with ceftazidime-avibactam and aztreonam.

Authors:  Majed F Alghoribi; Moayad Alqurashi; Liliane Okdah; Bassam Alalwan; Yahya S AlHebaishi; Abdulmajeed Almalki; Maha A Alzayer; Abdulrahman A Alswaji; Michel Doumith; Mazin Barry
Journal:  Sci Rep       Date:  2021-05-06       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.